A dose and schedule finding study of gemcitabine and etoposide in patients with progressive non-small cell lung cancer after platinum containing chemotherapy-Reference-Cited by-同舟云学术

A dose and schedule finding study of gemcitabine and etoposide in patients with progressive non-small cell lung cancer after platinum containing chemotherapy

Published:1999-05 Issue:2 Volume:24 Page:115-121
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Biesma B.,Smit E.F.,Postmus P.E.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference24 articles.

1. Chemotherapy for non-small cell lung cancer;Smit,1995

2. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;Br Med J,1995

3. Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study;Abratt;J Clin Oncol,1994

4. Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study;Anderson;J Clin Oncol,1994

5. Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study;Gatzemeier;Eur J Cancer,1996

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer;Molecular Cancer Therapeutics;2010-08

2. A Retrospective Analysis of Second-Line Chemotherapy or Best Supportive Care in Patients with Advanced-Stage Non–Small-Cell Lung Cancer;Clinical Lung Cancer;2006-07

3. Vinflunine – an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study;British Journal of Cancer;2006-04-25

4. Randomized Study of Maintenance Vinorelbine in Responders With Advanced Non-Small-Cell Lung Cancer;JNCI Journal of the National Cancer Institute;2005-04-05

5. Weekly Vinorelbine and Docetaxel as Second-Line Chemotherapy for Pretreated Non-Small Cell Lung Cancer Patients: a Phase I-II Trial;Journal of Chemotherapy;2004-08